The Journal of Immunology, Vol 146, Issue 8 2522-2529, Copyright © 1991 by American Association of Immunologists

ARTICLES

Reconstitution of an active surface CD2 by DNA transfer in CD2-CD3+ Jurkat cells facilitates CD3-T cell receptor-mediated IL-2 production

H Makni, JS Malter, JC Reed, S Nobuhiko, G Lang, D Kioussis, G Trinchieri and M Kamoun
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

To investigate the requirements for CD2 expression in the activation of T lymphocytes via the CD3-TCR complex, we produced and characterized a series of CD2-variants of the IL-2 producing Jurkat leukemia cell line, J32 (surface phenotype, CD2+, CD3+, CD28+). These mutants were derived by radiation and immunoselection, and were cloned under limiting dilution conditions. A total of 3 out of 30 of these mutants selectively lost the expression of both CD2 surface molecules and CD2 mRNA, and retained the expression of the CD3-TCR complex and the CD28 molecule. A mitogenic combination of anti-CD2 antibodies (9.6 + 9-1) failed to stimulate activation of these variants as measured by mobilization of intracellular Ca2+ and by IL-2 production. The CD2- mutants stimulated with anti-CD3 or anti-TCR mAb revealed an 8- to 32- fold decrease in IL-2 production and IL-2 mRNA accumulation as compared with the parental cells. No alteration of CD3-TCR-induced mobilization of intracellular Ca2+ was observed in the CD2- mutants. Reconstitution of CD2 expression by gene transfer in two J32 CD2- mutants restored IL- 2 production and IL-2 mRNA accumulation in responses to both anti-CD2 and anti-CD3-TCR mAb. These results are the first direct demonstration of the requirement for CD2 molecules in optimizing IL-2 response in human T cells stimulated via CD3-TCR complex.

This article has been cited by other articles:

				S. M. Vogel, R. D. Minshall, M. Pilipovic', C. Tiruppathi, and A. B. Malik Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1512 - L1522. [Abstract] [Full Text] [PDF]

				L. S. Metelitsa, O. V. Naidenko, A. Kant, H.-W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells J. Immunol., September 15, 2001; 167(6): 3114 - 3122. [Abstract] [Full Text] [PDF]

				E. Chuang, K.-M. Lee, M. D. Robbins, J. M. Duerr, M.-L. Alegre, J. E. Hambor, M. J. Neveu, J. A. Bluestone, and C. B. Thompson Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases J. Immunol., February 1, 1999; 162(3): 1270 - 1277. [Abstract] [Full Text] [PDF]

				W. L. Stanford, S. Haque, R. Alexander, X. Liu, A. M. Latour, H. R. Snodgrass, B. H. Koller, and P. M. Flood Altered Proliferative Response by T Lymphocytes of Ly-6A (Sca-1) Null Mice J. Exp. Med., August 29, 1997; 186(5): 705 - 717. [Abstract] [Full Text] [PDF]